Editorial Team

The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.

Honorary Editor-in-Chief

Charles M. Balch, MD, FACS

Professor of Surgery, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Editors-in-Chief

Shukui Qin, MD, PhD

Chair of Chinese Society of Clinical Oncology (CSCO); Deputy Director of People’s Liberation Army (PLA) 81 Hospital (Nanjing, China); Director of Cancer Center of Chinese PLA, China.

Jiade J. Lu, MD, MBA

China National Distinguished Expert; Executive Vice President, Shanghai Proton and Heavy Ion Center (SPHIC); Professor of Clinical Oncology, Fudan University School of Medicine, China

Associate Editors-in-Chief

Ghassan Abou-Alfa, MD, MBA (Liver Cancer)

Memorial Sloan Kettering Cancer Center, Weill Medical College at Cornell University, New York, USA.

Eileen M. O'Reilly, MD (Pancreatic Cancer)

David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA

Wenyin Shi, MD, PhD

Department of Radiation Oncology, Thomas Jefferson University; Jefferson Brain Tumor Center; Jefferson Cutaneous Lymphoma Center, Philadelphia, Pennsylvania, USA

Andrew X. Zhu

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

Editorial Board (Breast Oncology)

Tomonori Kawasaki, MD, PhD

Department of Pathology, Saitama Medical University International Medical Center, Hidaka, Japan

Suzanne Klimberg, MD, PhD, FACS

Cancer Institute, University of Texas Medical Branch at Galveston, Galveston, TX, USA

Yutaka Yamamoto, MD, PhD

Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan

Editorial Board (Hematological Oncology)

Onder Alpdogan, MD

Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA

Andrea Gallamini

Research, Innovation and Statistics Department, A. Lacassagne Cancer Center, Nice, France

Panagiotis J. Vlachostergios, MD, PhD (hematological oncology)

Department of Medicine, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY, USA.

Editorial Board (Gastrointestinal Oncology)

Rajiv Agarwal, MD, MSCI

Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

Francesco Ardito, MD, PhD

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Catholic University of the Sacred Heart, Rome, Italy

Savio George Alberto da Piedade Barreto, MS, FRACS, PhD

Hepatobiliary & Liver Transplant Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia

Tanios Bekaii-Saab, MD, FACP

Medical Director, Cancer Clinical Research Office, Section Chief and Vice-Chair, Division of Hematology/Oncology, Consultant, Mayo Clinic, Phoenix, Arizona, USA

Akhil Chawla

Division of Surgical Oncology, Department of Surgery, Northwestern Medicine Regional Medical Group, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Michael D. Chuong, MD, FACRO

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, USA

Romain Coriat

Professor of gastroenterology and digestive oncology, Head of Gastroenterology, endoscopy and digestive endoscopy Unit, Université Paris Cité, Cochin Hospital, AP-HP, Paris, France

Marco Falasca, PhD

Professor of Metabolism, Metabolic Signalling Group, Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, Australia

Yuman Fong, M.D.

Sangiacomo Chair and Chairman of the Department of Surgery, City of Hope Medical Center, Duarte, USA.

Francesco Giudici, MD, PhD

Careggi University Hospital of Florence, Italy

Jin He

Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

David Ilson, MD, PhD

Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Hiromichi Ito, MD

Division of Hepatobiliary and Pancreatic Surgery, Japanse Foundation for Cancer Research, Cancer Insitute Hospital, Japan

Matthew H. G. Katz, MD

Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA

David J Kerr, MA, MD, DSc, FRCP (Glas, Lon & Edin), FRCGP (Hon)

Co-Director, Oxford-Sichuan Gastrointestinal Cancer Centre Nuffield Dept Clinical and Laboratory Sciences, University of Oxford, Weill-Cornell College of Medicine, New York, USA

Yoji Kishi

Department of Surgery, National Defense Medical College, Saitama, Japan

Koji Komori, MD, PhD

Department of Gastroenterological Surgery Aichi Cancer Center Hospital, Nagoya, Aichi, Japan

Geoffrey Ku, MD

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA

Giovanni Battista Levi Sandri, MD, PhD

Department of General Surgery and Transplantation, San Camillo Forlanini Hospital, Rome, Italy

Eric C.H. Lai, FRACS

Consultant, Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China

Jose J. G. Marin

Head of Dept. Physiology & Pharmacology UNIVERSITY of SALAMANCA Experimental Hepatology and Drug Targeting (HEVEPHARM) Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd) Salamanca Institute for Biomedical Research (IBSAL), Salamanca, Spain

Bruce D. Minsky, MD

Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA

Michele Molinari, MD, MHS, FACS

Professor of Surgery, Division of Transplant Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

John P. Neoptolemos, MA, MB, BChir, MD, FRCS, FMedSci, MAE, Professor of Surgery

Department of General Surgery,University of Heidelberg, Baden-Württemberg, Germany

Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA

Professor and Chair, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Wexner Medical Center at The Ohio State University, Columbus, USA

Yoshihiro Sakamoto, MD

Professor and Chairman Department of Hepato-Biliary-Pancreatic Surgery Kyorin University Hospital, Tokyo, Japan

Mario Serradilla-Martín, MD, PhD, FACS, FEBS (HPB)

University of Zaragoza. Division of HPB Surgery, Department of Surgery, Miguel Servet University Hospital, Zaragoza, Spain

Adam C. Yopp

Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, USA

Maurizio Zizzo, MD, PhD

Surgical Oncology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Arcispedale Santa Maria Nuova di Reggio Emilia, Italy

Editorial Board (Head and Neck Oncology)

Raffaele Addeo, MD, PhD

Director, U.O.C. Oncology, Oncology Complex Unit, San Giovanni Di Dio Hospital, Frattamaggiore (NA), Italy

Anne W. M. Lee, MD

Clinical Oncology Center, The University of Hong Kong - Shenzhen Hospital, China

Jean-Claude M. Rwigema, MD

Department of Radiation Oncology, Mayo Clinic, Phoenix, USA

Christophe Le Tourneau, MD, PhD

INSERM U900 Research Unit, Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris, France

Editorial Board (Melanoma)

Jason J. Luke, MD, FACP

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Dirk Schadendorf, MD

Department of Dermatology, University Hospital Essen, Essen, Germany

John F Thompson, MD

Melanoma Institute Australia and The University of Sydney, Sydney, Australia

Editorial Board (Neuro-Oncology)

Jon Glass, MD

Departments of Neurology and Neurological Surgery; Vickie and Jack Farber Institute for Neuroscience and Sidney Kimmel Cancer Center; Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Simon S. Lo, MB, ChB, FACR, FASTRO

Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA

Rimas V. Lukas

Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Shearwood McClelland III, MD

Director of Spine Radiation Oncology Departments of Radiation Oncology and Neurological Surgery University Hospitals Seidman Cancer Center Case Western Reserve University School of Medicine Cleveland, Ohio

Joshua D. Palmer, MD

Assistant Professor, Department of Radiation Oncology, Assistant Professor of Neurosurgery, The James Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

Michael Weller, MD

Department of Neurology, University Hospital Zurich, Zurich, Switzerland

Editorial Board (Neuroendocrine Neoplasm)

Amr Mohamed, MD

Assistant Professor, Gastrointestinal Medical Oncology, Department of Hematology and Oncology, UH Seidman Cancer Center, University Hospitals, Case Western Reserve University, USA

Editorial Board (Thoracic Oncology)

Giuseppe Luigi Banna, MD

Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy

Aakash Desai, MBBS, MPH (Thoracic Oncology)

Division of Medical Oncology, Mayo Clinic, Rochester, USA.

Bin S. Teh, MD, FACR, FASTRO, FACRO

Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center, Institute for Academic Medicine, Research Institute, Weill Cornell Medicine, Houston, Texas, USA

Editorial Board (Urologic Oncology)

Davide Campobasso, MD (Urologic Oncology)

Urology Unit of the Univeristy Hospital of Parma, Italy

Darren Ming-Chun Poon, MBChB, FRCR, FHKCR. FHKAM (Radiology)

Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China; Department of Clinical Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong, China

Editorial Board (Statistics in Oncology Clinical Trials)

Qian Shi, PhD

Consultant in Quantitative Science, Professor of Biostatistics and Oncology at Mayo Clinic and Mayo College of Medicine, in Rochester, MN, USA

Xiaofei Wang, PhD

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA

Jun (Vivien) Yin, PhD

Cancer Center Statistics, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA

Editorial Board (Gynecologic Oncology)

Kevin V. Albuquerque, MBBS, M.S., F.R.C.S., DABR

Harold C Simmons Comprehensive Cancer Center, Department of Radiation Oncology, U.T. Southwestern Medical Center, Dallas, Texas, USA

Peixin Dong, MD, PhD

Department of Obstetrics and Gynecology, Hokkaido University, Sapporo, Japan

Denis Querleu

Institut Bergonié Cancer Center, Bordeaux, France

Yong-Sang Song, MD, PhD

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea

Editorial Board (Interventional Oncology)

David C. Madoff

Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA

Editorial Board (Sarcoma)

Raphael E. Pollock, MD, PhD

The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA

William W. Tseng, MD

University of Southern California, Keck School of Medicine, Los Angeles, California, USA

Editorial Board (Liver Cancer)

Keiichi Kubota

Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

José L. Mauriz, PhD

Head of Institute of Biomedicine (IBIOMED), Professor at Department of Biomedical Sciences, University of León, León, Spain; Center of the Study of Liver and Gastrointestinal Diseases (CIBERehd), Madrid, Spain